1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Route of Administrations
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Psoriasis Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1.
By Type of Treatment
(Biologic Drugs, Small Molecule Systemic Drugs, Tropical Therapies)
5.2.2. By Mechanism of Action (TNF Alpha Inhibitors, PDE4
Inhibitors, Interleukin Inhibitors, Others)
5.2.3.
By Route of
Administration (Oral, Parenteral, Topical)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
6.
North America Psoriasis
Drugs Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Type of Treatment
6.2.2.
By Mechanism of
Action
6.2.3.
By Route of
Administration
6.2.4.
By Country
6.3. North America: Country Analysis
6.3.1. United States Psoriasis Drugs Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type of Treatment
6.3.1.2.2.
By Mechanism of
Action
6.3.1.2.3.
By Route of
Administration
6.3.2. Canada Psoriasis Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type of Treatment
6.3.2.2.2.
By Mechanism of
Action
6.3.2.2.3.
By Route of
Administration
6.3.3. Mexico Psoriasis Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type of Treatment
6.3.3.2.2.
By Mechanism of
Action
6.3.3.2.3.
By Route of
Administration
7.
Europe Psoriasis
Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Treatment
7.2.2. By Mechanism of Action
7.2.3. By Route of Administration
7.3. Europe: Country Analysis
7.3.1. Germany Psoriasis Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type of Treatment
7.3.1.2.2.
By Mechanism of
Action
7.3.1.2.3.
By Route of
Administration
7.3.2. United Kingdom Psoriasis Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type of Treatment
7.3.2.2.2.
By Mechanism of
Action
7.3.2.2.3.
By Route of
Administration
7.3.3. Italy Psoriasis Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Type of Treatment
7.3.3.2.2.
By Mechanism of
Action
7.3.3.2.3.
By Route of
Administration
7.3.4. France Psoriasis Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type of Treatment
7.3.4.2.2.
By Mechanism of
Action
7.3.4.2.3.
By Route of
Administration
7.3.5. Spain Psoriasis Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type of Treatment
7.3.5.2.2.
By Mechanism of
Action
7.3.5.2.3.
By Route of
Administration
8.
Asia-Pacific Psoriasis
Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Treatment
8.2.2. By Mechanism of Action
8.2.3. By Route of Administration
8.3. Asia-Pacific: Country Analysis
8.3.1. China Psoriasis Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type of Treatment
8.3.1.2.2.
By Mechanism of Action
8.3.1.2.3.
By Route of
Administration
8.3.2. India Psoriasis Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type of Treatment
8.3.2.2.2.
By Mechanism of
Action
8.3.2.2.3.
By Route of
Administration
8.3.3. Japan Psoriasis Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type of Treatment
8.3.3.2.2.
By Mechanism of
Action
8.3.3.2.3.
By Route of
Administration
8.3.4. South Korea Psoriasis Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type of Treatment
8.3.4.2.2.
By Mechanism of Action
8.3.4.2.3.
By Route of
Administration
8.3.5. Australia Psoriasis Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type of Treatment
8.3.5.2.2.
By Mechanism of
Action
8.3.5.2.3.
By Route of
Administration
9.
South America Psoriasis
Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Treatment
9.2.2. By Mechanism of Action
9.2.3. By Route of Administration
9.3. South America: Country Analysis
9.3.1. Brazil Psoriasis Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type of Treatment
9.3.1.2.2.
By Mechanism of
Action
9.3.1.2.3.
By Route of
Administration
9.3.2. Argentina Psoriasis Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type of Treatment
9.3.2.2.2.
By Mechanism of
Action
9.3.2.2.3.
By Route of Administration
9.3.3. Colombia Psoriasis Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type of Treatment
9.3.3.2.2.
By Mechanism of
Action
9.3.3.2.3.
By Route of
Administration
10.
Middle East and
Africa Psoriasis Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Treatment
10.2.2. By Mechanism of Action
10.2.3. By Route of Administration
10.3. MEA: Country Analysis
10.3.1. South Africa Psoriasis Drugs Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Type of Treatment
10.3.1.2.2.
By Mechanism of
Action
10.3.1.2.3.
By Route of
Administration
10.3.2. Saudi Arabia Psoriasis Drugs Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Type of Treatment
10.3.2.2.2.
By Mechanism of
Action
10.3.2.2.3.
By Route of
Administration
10.3.3. UAE Psoriasis Drugs Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Type of Treatment
10.3.3.2.2.
By Mechanism of
Action
10.3.3.2.3.
By Route of
Administration
11. Market Dynamics
11.1.
Drivers &
Challenges
12. Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Psoriasis Drugs Market: SWOT Analysis
14. Competitive Landscape
14.1. Business Overview
14.2. Mechanism of Action Offerings
14.3. Recent Developments
14.4. Key Personnel
14.5. SWOT Analysis
14.5.1. Biogen Idec
14.5.2. Boehringer Ingelheim
14.5.3. Celgene Corporation
14.5.4. Dr.Reddy`s Laboratories
14.5.5. Eli Lilly and Company
14.5.6. Forward Pharma
14.5.7. Johnson and Johnson (Janssen Biotech
Inc.)
14.5.8. Leo Pharma AS
14.5.9. Merck and Co. Inc.
14.5.10.
Novartis AG
14.5.11.
Pfizer Inc.
15.
Strategic Recommendations
16. About Us & Disclaimer